TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Double Bond Pharmaceutical International AB (publ)
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
1,089
|
1,370
|
1,243 |
| Financial expenses |
5,488
|
3,902
|
0 |
| Earnings before taxes |
-7,112
|
-17,338
|
-15,160 |
| EBITDA |
-1,445
|
-13,243
|
-14,968 |
| Total assets |
12,350
|
11,597
|
15,390 |
| Current assets |
5,602
|
5,018
|
6,497 |
| Current liabilities |
8,350
|
6,242
|
3,319 |
| Equity capital |
4,000
|
5,355
|
12,071 |
| - share capital |
5,356
|
4,768
|
3,163 |
| Employees (average) |
9
|
10
|
10 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
32.4%
|
46.2%
|
78.4% |
| Turnover per employee |
121
|
137
|
124 |
| Profit as a percentage of turnover |
-653.1%
|
-1265.5%
|
-1219.6% |
| Return on assets (ROA) |
-13.1%
|
-115.9%
|
-98.5% |
| Current ratio |
67.1%
|
80.4%
|
195.8% |
| Return on equity (ROE) |
-177.8%
|
-323.8%
|
-125.6% |
| Change turnover |
-281
|
127
|
287 |
| Change turnover % |
-21%
|
10%
|
30% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-10%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.